European and South Korean authorities are vying for Gilead Sciences' potential COVID-19 treatment, remdesivir, even though the drugmaker has yet ...
FILE PHOTO: An ampule of remdesivir is pictured during a news conference at the University Hospital Eppendorf in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease continues. Ulrich Perrey/Pool via REUTERSREUTERS: European and South Korean authorities are vying for Gilead Sciences' potential COVID-19 treatment, remdesivir, even though the drugmaker has yet to gain regulatory approval in either market and is still ramping up production of the anti-viral drug.
The European Medicines Agency noted it has not yet received an application from the US drugmaker, but said its human medicines committee's timeline to assess the drug would be"reduced to the absolute minimum,". On Friday, South Korean health authorities said they would request imports of remdesivir to treat COVID-19, as new outbreaks of the disease flare after social distancing restrictions were eased.This month, the US Department of Health and Human Services said Gilead had committed to supply US hospitals with about 607,000 vials of remdesivir, about 40per cent of the total 1.5 million-vial donation.
The United States, the world's biggest pharmaceutical market, this month granted emergency use authorisation for remdesivir in COVID-19, but has yet to approve the broader use of the drug.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Green Pulse Podcast: Will cleaner air in South-east Asia during Covid-19 lockdowns last?Green Pulse is an environmental podcast series at The Straits Times which analyses the beat of the changing environment, from biodiversity conservation to climate change. . Read more at straitstimes.com.
Read more »
Indonesia to keep prescribing two malaria drugs for Covid-19 despite bans in EuropeJAKARTA (REUTERS) - Indonesia will continue to prescribe two anti-malaria drugs for coronavirus patients but monitor their use closely, a spokesman for Indonesia's Covid-19 taskforce said on Thursday (May 28), after some European nations banned the drug over safety concerns.. Read more at straitstimes.com.
Read more »
Former South Korean 'comfort women' leader apologises for 'banking errors'SEOUL: The former leader of an advocacy group for South Korean victims of Japanese wartime sexual violence on Friday (May 29) denied allegations ...
Read more »
South Korea reports 79 new coronavirus cases, most since Apr 5South Korea reported 79 new coronavirus cases on Thursday, the Korea Centers for Disease Control and Prevention said, the largest one day increase ...
Read more »
US-China accident risk is highest in the South China SeaSINGAPORE (BLOOMBERG) - As China and the US trade barbs over everything from trade to Covid-19 to Hong Kong, the two powers are at greater risk of careering into physical confrontation. And nowhere are their warships and fighter jets coming as close to each other, with as much frequency, as the South China Sea.. Read more at straitstimes.com.
Read more »